Your browser doesn't support javascript.
loading
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors.
Takagi, Masatoshi; Ogawa, Chitose; Iehara, Tomoko; Aoki-Nogami, Yuki; Ishibashi, Eri; Imai, Minoru; Kimura, Toshimi; Nagata, Masashi; Yasuhara, Masato; Masutani, Mitsuko; Yoshimura, Kenichi; Tomizawa, Daisuke; Ogawa, Atsushi; Yonemori, Kan; Morishita, Aoi; Miyamoto, Satoshi; Takita, Junko; Kihara, Tetsuro; Nobori, Kiyoshi; Hasebe, Kazuhisa; Miya, Fuyuki; Ikeda, Sadakatsu; Shioda, Yoko; Matsumoto, Kimikazu; Fujimura, Junya; Mizutani, Shuki; Morio, Tomohiro; Hosoi, Hajime; Koike, Ryuji.
Afiliación
  • Takagi M; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Ogawa C; Department of Pediatric Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Iehara T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.
  • Aoki-Nogami Y; Department of Pediatric Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Ishibashi E; University Research Administration Division, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Imai M; University Research Administration Division, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Kimura T; Department of Pharmacy, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
  • Nagata M; Department of Pharmacokinetics and Pharmacodynamics, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo.
  • Yasuhara M; Department of Pharmacokinetics and Pharmacodynamics, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo.
  • Masutani M; Department of Molecular and Genomic Biomedicine, Center for Bioinformatics and Molecular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Yoshimura K; Innovative Clinical Research Center, Kanazawa University, Kanazawa, Ishikawa, Japan.
  • Tomizawa D; Future Medical Center, Hiroshima University Hospital, Minami-ku, Hiroshima, Japan.
  • Ogawa A; National Center for Child Health and Development, Children's Cancer Center, Setagaya-ku, Tokyo, Japan.
  • Yonemori K; Pediatrics, Niigata Cancer Center Hospital, Chuo-ku, Niigata, Japan.
  • Morishita A; Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.
  • Miyamoto S; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Takita J; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Kihara T; Department of Pediatrics, Kyoto University, Sakyo-ku, Kyoto, Japan.
  • Nobori K; University Research Administration Division, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Hasebe K; Medical Innovation Promotion Center, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Miya F; University Research Administration Division, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Ikeda S; Department of Medical Science Mathematics, Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Shioda Y; Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Matsumoto K; National Center for Child Health and Development, Children's Cancer Center, Setagaya-ku, Tokyo, Japan.
  • Fujimura J; National Center for Child Health and Development, Children's Cancer Center, Setagaya-ku, Tokyo, Japan.
  • Mizutani S; Department of Pediatrics and Adolescent Medicine, Juntendo University, School of Medicine, Bunkyo-ku, Tokyo, Japan.
  • Morio T; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Hosoi H; Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.
  • Koike R; Department of Pediatrics, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, Japan.
Cancer ; 128(15): 2949-2957, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35593736
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neuroblastoma / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Child / Humans Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neuroblastoma / Antineoplásicos Tipo de estudio: Clinical_trials Límite: Adult / Child / Humans Idioma: En Revista: Cancer Año: 2022 Tipo del documento: Article País de afiliación: Japón